Schizophrenia: genetic insights with clinical potential

Olav B Smeland¹, Ole A Andreassen^{2

3}

Affiliations

¹ NORMENT Centre, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
² NORMENT Centre, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. ole.andreassen@medisin.uio.no.
³ KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway. ole.andreassen@medisin.uio.no.

Comment

Olav B Smeland et al. Nat Rev Neurol. 2022 Mar.

. 2022 Mar;18(3):129-130.

doi: 10.1038/s41582-021-00613-6.

Olav B Smeland¹, Ole A Andreassen^{2

3}

¹ NORMENT Centre, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
² NORMENT Centre, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. ole.andreassen@medisin.uio.no.
³ KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway. ole.andreassen@medisin.uio.no.

No abstract available

Comment on

Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.
Zhang R, Sjölander A, Ploner A, Lu D, Bulik CM, Bergen SE. Zhang R, et al. Mol Psychiatry. 2022 Mar;27(3):1448-1454. doi: 10.1038/s41380-021-01387-5. Epub 2021 Nov 19. Mol Psychiatry. 2022. PMID: 34799693 Free PMC article.
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders.
Alkelai A, Greenbaum L, Docherty AR, Shabalin AA, Povysil G, Malakar A, Hughes D, Delaney SL, Peabody EP, McNamara J, Gelfman S, Baugh EH, Zoghbi AW, Harms MB, Hwang HS, Grossman-Jonish A, Aggarwal V, Heinzen EL, Jobanputra V, Pulver AE, Lerer B, Goldstein DB. Alkelai A, et al. Mol Psychiatry. 2022 Mar;27(3):1435-1447. doi: 10.1038/s41380-021-01383-9. Epub 2021 Nov 19. Mol Psychiatry. 2022. PMID: 34799694

1. Charlson, F. J. et al. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016. Schizophr. Bull. 44, 1195–1203 (2018). - DOI
1. Smeland, O. B., Frei, O., Dale, A. M. & Andreassen, O. A. The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology. Nat. Rev. Neurol. 16, 366–379 (2020). - DOI
1. The Schizophrenia Working Group of the Psychiatric Genomics Consortium. Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia. Preprint at https://www.medrxiv.org/content/10.1101/2020.09.12.20192922v1 (2020).
1. Singh, T., Neale, B. M. & Daly, M. J. Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia. Preprint at https://www.medrxiv.org/content/10.1101/2020.09.18.20192815v1 (2020).
1. Smeland, O. B. & Andreassen, O. A. Polygenic risk scores in psychiatry – large potential but still limited clinical utility. Eur. Neuropsychopharmacol. 51, 68–70 (2021). - DOI